Portal and Superior Mesenteric Venous Thrombosis Treated with Urokinase Infusion via Superior Mesenteric Artery.
- Author:
Hyeug LEE
1
;
Tae Ho KIM
;
Hyun Jong OH
;
Jin Il KIM
;
Soo Heon PARK
;
Joon Yeol HAN
;
Jae Kwang KIM
;
Kyu Young CHOI
;
In Sik CHUNG
;
Sang Hoon LEE
;
Seong Tai HAHN
Author Information
1. Division of Gastroenterology, Departments of Internal Medicine, St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea. jyhan@catholic.ac.kr
- Publication Type:Case Reports ; English Abstract
- Keywords:
Mesenteric venous thrombosis;
Urokinase
- MeSH:
Adult;
Humans;
Infusions, Intra-Arterial;
Male;
Mesenteric Artery, Superior;
Mesenteric Vascular Occlusion/*drug therapy;
Mesenteric Veins;
*Portal Vein;
*Thrombolytic Therapy;
Urokinase-Type Plasminogen Activator/*administration & dosage;
Venous Thrombosis/*drug therapy
- From:The Korean Journal of Gastroenterology
2006;48(1):46-50
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Portal and mesenteric venous thrombosis is an uncommon disease, but clinically important, because it accounts for 5% to 15% of acute mesenteric ischemia. The diagnosis is often delayed because the conditions are nonspecific abdominal symptoms. In addition, when this occurs in young individual without any known predisposing factor, the diagnosis may become even more difficult. The treatment of mesenteric venous thrombosis involves anticoagulation therapy alone or in combination with surgery. The addition of thrombolytic therapy to the treatment of portal and mesenteric venous thrombosis may enhance the clearance of thrombus and hasten the clinical improvements. We present a case of mesenteric venous thrombosis treated with catheter-directed infusion of urokinase via the superior mesenteric artery and systemic anticoagulation.
